Neurocrine biosciences to participate at investor conferences in december

The 7th annual evercore healthconx conference on december 3 citi's 2024 global healthcare conference on december 4 san diego , nov. 26, 2024 /prnewswire/ -- neurocrine biosciences, inc. (nasdaq: nbix) will participate at two upcoming investor conferences in december. chief executive officer kyle gano, chief financial officer matt abernethy, and vice-president of investor relations todd tushla will present at: the 7th annual evercore healthconx conference at 10:50 a.m.
NBIX Ratings Summary
NBIX Quant Ranking